Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/168021
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Letang, Emilio | - |
dc.contributor.author | Ellis, Jayne | - |
dc.contributor.author | Naidoo, Kogieleum | - |
dc.contributor.author | Casas, Esther C. | - |
dc.contributor.author | Sánchez, Paquita | - |
dc.contributor.author | Hassan-Moosa, Razia | - |
dc.contributor.author | Cresswell, Fiona | - |
dc.contributor.author | Miró Meda, José M. | - |
dc.contributor.author | García-Basteiro, Alberto L. | - |
dc.date.accessioned | 2020-07-07T15:12:38Z | - |
dc.date.available | 2021-01-10T06:10:19Z | - |
dc.date.issued | 2020-01-10 | - |
dc.identifier.issn | 0300-2896 | - |
dc.identifier.uri | http://hdl.handle.net/2445/168021 | - |
dc.description.abstract | Despite wide antiretroviral scale-up during the past two decades resulting in declining new infections and mortality globally, HIV-associated tuberculosis remains as a major public health concern. Tuberculosis is the leading HIV-associated opportunistic infection and the main cause of death globally and, particularly, in resource-limited settings. Several challenges exist regarding diagnosis, global implementation of latent tuberculosis treatment, management of active tuberculosis, delivery of optimal patient-centered TB and HIV prevention and care in high burden countries. In this article we review the advances on pathogenesis, diagnosis, and treatment after nearly two decades of global roll-out of antiretroviral therapy and discuss the current challenges for the global control of tuberculosis-HIV co-infection. | - |
dc.format.extent | 9 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier | - |
dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1016/j.arbres.2019.11.015 | - |
dc.relation.ispartof | Archivos de Bronconeumologia, 2020, vol. 56, num. 7, p. 446-454 | - |
dc.relation.uri | https://doi.org/10.1016/j.arbres.2019.11.015 | - |
dc.rights | cc-by-nc-nd (c) Elsevier, 2020 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es | - |
dc.source | Articles publicats en revistes (Medicina) | - |
dc.subject.classification | Tuberculosi | - |
dc.subject.classification | VIH (Virus) | - |
dc.subject.classification | Antiretrovirals | - |
dc.subject.other | Tuberculosis | - |
dc.subject.other | HIV (Viruses) | - |
dc.subject.other | Antiretroviral agents | - |
dc.title | Tuberculosis-HIV co-infection: Progress and challenges after two decades of global antiretroviral treatment roll-out | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/acceptedVersion | - |
dc.identifier.idgrec | 695890 | - |
dc.date.updated | 2020-07-07T15:12:38Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 31932150 | - |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (ISGlobal) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
695890.pdf | 1.9 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License